
RS 504393
CAS No. 300816-15-3
RS 504393( —— )
Catalog No. M20120 CAS No. 300816-15-3
RS 504393 is a highly selective CCR2 chemokine receptor antagonist (IC50s: 89 nM and > 100 μM for human recombinant CCR2 and CCR1).
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 88 | In Stock |
![]() ![]() |
10MG | 151 | In Stock |
![]() ![]() |
25MG | 332 | In Stock |
![]() ![]() |
50MG | 498 | In Stock |
![]() ![]() |
100MG | 718 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameRS 504393
-
NoteResearch use only, not for human use.
-
Brief DescriptionRS 504393 is a highly selective CCR2 chemokine receptor antagonist (IC50s: 89 nM and > 100 μM for human recombinant CCR2 and CCR1).
-
DescriptionRS 504393 is a highly selective CCR2 chemokine receptor antagonist (IC50s: 89 nM and > 100 μM for human recombinant CCR2 and CCR1).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAutophagy
-
TargetCCR
-
RecptorCCR2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number300816-15-3
-
Formula Weight417.51
-
Molecular FormulaC25H27N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO: 10 mg/mL (23.95 mM); Water: Insoluble
-
SMILESCc1oc(nc1CCN1CCC2(CC1)OC(=O)Nc1ccc(C)cc21)-c1ccccc1
-
Chemical Name6-Methyl-1'-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-spiro[4H-31-benzoxazine-44'-piperidin]-2(1H)-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Mirzadegan T et al. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J Biol Chem. 2000 Aug 18;275(33):25562-71.
molnova catalog



related products
-
CCR4 antagonist 3-1
CCR4 antagonist 3-1 is a less active chemokine receptor 4 (CCR4) antagonist that inhibits [125I]TARC (thymus and activation-regulated chemokine) with an IC50 value of 1.7 μM.
-
Leronlimab
Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody with both anti-HIV and anti-tumor activity, inhibiting CCR-mediated HIV-1 virus and cancer cell metastasis in mouse tumor models. Leronlimab can be used to study HIV, non-alcoholic steatohepatitis (NASH), and breast cancer.
-
Arteether
Arteether, a new antimalarial drug.